PMID- 33015331 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201006 IS - 2364-3722 (Print) IS - 2196-9736 (Electronic) IS - 2196-9736 (Linking) VI - 8 IP - 10 DP - 2020 Oct TI - Endoscopic submucosal dissection and tunneling procedures using a novel all-in-one bipolar device. PG - E1302-E1307 LID - 10.1055/a-1220-6562 [doi] AB - Background and study aims Recent innovations in devices and techniques have revolutionized the field of endoscopic resection procedures. In this study, we evaluated the safety and feasibility of endoscopic submucosal dissection and tunneling procedures with a novel, multipurpose bipolar device. Patients and methods Data from consecutive patients who underwent per-oral endoscopic myotomy (POEM), submucosal tunneling endoscopic resection (STER), and endoscopic submucosal dissection (ESD) using a novel bipolar device (December 2019 to February 2020) were analyzed retrospectively. Procedure duration, technical success, and adverse events (AEs) were recorded. Results A total of 10 procedures were performed using the novel bipolar device during the study period. The procedures included POEM (n = 7), STER for esophageal sub-epithelial tumor (n = 1), ESD for rectal polyp (n = 1), and gastric neuroendocrine tumor (n = 1). POEM was successfully completed in all patients. In patients who underwent STER and ESD, en-bloc resection was achieved in all. Mean procedure time for submucosal tunneling procedures (POEM and STER) was 59.12 +/- 31.12 minutes. The procedures were completed without the requirement for exchange of accessories in eight cases (80 %). There were no major AEs. Mild and moderate AEs occurred during POEM and included capno-peritoneum (n = 1), retroperitoneal CO (2) (n = 1), and empyema (n = 1). Conclusion ESD and tunneling procedures can be safely performed without the need for exchange of accessories using a novel bipolar device. Randomized comparison with conventional knives isrequired to confirm the utility of this device. CI - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). FAU - Nabi, Zaheer AU - Nabi Z AD - Asian Institute of Gastroenterology - Medical Gastroenterology, Hyderabad, India. FAU - Chavan, Radhika AU - Chavan R AD - Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India. FAU - Ramchandani, Mohan AU - Ramchandani M AD - Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India. FAU - Tsiamoulos, Zacharias AU - Tsiamoulos Z AD - St. Mark's Hospital - Gastroenterology, Harrow, UK. FAU - Basha, Jahanqeer AU - Basha J AD - PGIMER - Gastroenterology, Chandigarh, India. FAU - Goud, Rajesh AU - Goud R AD - Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India. FAU - Darisetty, Santosh AU - Darisetty S AD - Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India. AD - Asian Institute of Gastroenterology - Anesthesia, Hyderabad, India. FAU - Reddy, Nageshwar AU - Reddy N AD - Asian Institute of Gastroenterology - Gastroenterology, Hyderabad, India. LA - eng PT - Journal Article DEP - 20200922 PL - Germany TA - Endosc Int Open JT - Endoscopy international open JID - 101639919 PMC - PMC7511265 COIS- Competing interests Dr. Tsiamoulos is a consultant agreement for Creo Medical and has received educational grants from Norgine and loan equipment from Olympus and Pentax. EDAT- 2020/10/06 06:00 MHDA- 2020/10/06 06:01 PMCR- 2020/10/01 CRDT- 2020/10/05 06:22 PHST- 2020/04/09 00:00 [received] PHST- 2020/05/22 00:00 [accepted] PHST- 2020/10/05 06:22 [entrez] PHST- 2020/10/06 06:00 [pubmed] PHST- 2020/10/06 06:01 [medline] PHST- 2020/10/01 00:00 [pmc-release] AID - 10.1055/a-1220-6562 [doi] PST - ppublish SO - Endosc Int Open. 2020 Oct;8(10):E1302-E1307. doi: 10.1055/a-1220-6562. Epub 2020 Sep 22.